{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:24:21Z","timestamp":1792103061743,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:00:00Z","timestamp":1537920000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"OM Pharma, a company of Vifor Pharma Group","award":["BV"],"award-info":[{"award-number":["BV"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13052-018-0569-7","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T11:11:56Z","timestamp":1537960316000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Evidence that a primary anti-viral stimulation of the immune response by OM-85 reduces susceptibility to a secondary respiratory bacterial infection in mice"],"prefix":"10.1186","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4804-2421","authenticated-orcid":false,"given":"Giovanni A.","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Bessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Ballarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,26]]},"reference":[{"key":"569_CR1","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1378\/chest.120.6.2021","volume":"120","author":"R Guthrie","year":"2001","unstructured":"Guthrie R. Community-acquired lower respiratory tract infections: etiology and treatment. Chest. 2001;120:2021\u201334.","journal-title":"Chest"},{"key":"569_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(03)12162-9","volume":"361","author":"T Heikkinen","year":"2003","unstructured":"Heikkinen T, J\u00e4rvinen A. The common cold. Lancet. 2003;361:51\u20139.","journal-title":"Lancet"},{"key":"569_CR3","doi-asserted-by":"publisher","unstructured":"Brealey JC, Sly PD, Young PR, Chappell KJ. Viral bacterial co-infection of the respiratory tract during early childhood. FEMS Microbiol Lett. 2015;362(10): fnv062. \n                    https:\/\/doi.org\/10.1093\/femsle\/fnv062\n                    \n                  .","DOI":"10.1093\/femsle\/fnv062"},{"key":"569_CR4","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.4049\/jimmunol.1300014","volume":"191","author":"HE Ghoneim","year":"2013","unstructured":"Ghoneim HE, Thomas PG, McCullers JA. Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections. J Immunol. 2013;191:1250\u20139.","journal-title":"J Immunol"},{"key":"569_CR5","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1128\/JVI.80.4.1629-1636.2006","volume":"80","author":"V Avadhanula","year":"2006","unstructured":"Avadhanula V, Rodriguez CA, DeVincenzo JP, Webby RJ, Ulett GC, et al. Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type dependent manner. J Virol. 2006;80:1629\u201336.","journal-title":"J Virol"},{"key":"569_CR6","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1042\/BST0370811","volume":"37","author":"T Hussell","year":"2009","unstructured":"Hussell T, Cavanagh MM. The innate immune rheostat: influence on lung inflammatory disease and secondary bacterial pneumonia. Biochem Soc Trans. 2009;37:811\u20133.","journal-title":"Biochem Soc Trans"},{"key":"569_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10156-010-0097-x","volume":"17","author":"H Hishiki","year":"2011","unstructured":"Hishiki H, Ishiwada N, Fukasawa C, Hoshino T, Aizawa J, Ishikawa N, et al. Incidence of bacterial coinfection with respiratory syncytial virus bronchopulmonary infection in pediatric inpatients. J Infect Chemother. 2011;17:87\u201390.","journal-title":"J Infect Chemother"},{"key":"569_CR8","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1086\/656333","volume":"202","author":"JA McCullers","year":"2010","unstructured":"McCullers JA, McAuley JL, Browall S, Iverson AR, Boyd KL, Henriques Normark B. Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J Infect Dis. 2010;202:1287\u201395.","journal-title":"J Infect Dis"},{"key":"569_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nri2075","volume":"7","author":"O Levy","year":"2007","unstructured":"Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol. 2007;7:379\u201390.","journal-title":"Nat Rev Immunol."},{"key":"569_CR10","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/nri3312","volume":"12","author":"TR Klaenhammer","year":"2012","unstructured":"Klaenhammer TR, Kleerebezem M, Kopp MV, Rescigno M. The impact of probiotics and prebiotics on the immune system. Nat Rev Immunol. 2012;12:728\u201334.","journal-title":"Nat Rev Immunol."},{"key":"569_CR11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nri2871","volume":"10","author":"E von Mutius","year":"2010","unstructured":"von Mutius E, Vercelli D. Farm living: effects on childhood asthma and allergy. Nat Rev Immunol. 2010;10:861\u20138.","journal-title":"Nat Rev Immunol"},{"key":"569_CR12","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.jaci.2013.03.020","volume":"131","author":"PI Pfefferle","year":"2013","unstructured":"Pfefferle PI, Prescott SL, Kopp M. Microbial influence on tolerance and opportunities for intervention with prebiotics\/probiotics and bacterial lysates. J Allergy Clin Immunol. 2013;131:1453\u201363.","journal-title":"J Allergy Clin Immunol"},{"key":"569_CR13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1508749","volume":"375","author":"MM Stein","year":"2016","unstructured":"Stein MM, Hrusch CL, Gozdz J, Igartua C, Pivniouk V, Murray SE, et al. Innate Immunity and Asthma Risk in Amish and Hutterite Farm Children. N Engl J Med. 2016;375:411\u201321.","journal-title":"N Engl J Med"},{"key":"569_CR14","doi-asserted-by":"crossref","unstructured":"Del-Rio-Navarro BE, Espinosa-Rosales FJ, Flenady V, Sienra-Monge JJL. Immunostimulants for preventing respiratory tract infection in children. Evid-Based Child Health. 2012;7:629\u2013717.","DOI":"10.1002\/ebch.1833"},{"key":"569_CR15","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.anai.2015.02.008","volume":"114","author":"SC Kearney","year":"2015","unstructured":"Kearney SC, Dziekiewicz M, Feleszko W. Immunoregulatory and immunostimulatory responses of bacterial lysates in respiratory infections and asthma. Ann Allergy Asthma Immunol. 2015;114:364\u20139.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"569_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12519-010-0001-x","volume":"6","author":"UB Schaad","year":"2010","unstructured":"Schaad UB. OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review. World J Pediatr. 2010;6:5\u201312.","journal-title":"World J Pediatr"},{"key":"569_CR17","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jaci.2010.07.038","volume":"126","author":"CH Razi","year":"2010","unstructured":"Razi CH, Harmanci K, Abaci A, \u00d6zdemir O, H\u0131zl\u0131 S, Renda R, Keskin F. The immunostimulant OM-85 BV prevents wheezing attacks in preschool children. J Allergy Clin Immunol. 2010;126:763\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"569_CR18","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.intimp.2017.10.032","volume":"54","author":"J Yin","year":"2018","unstructured":"Yin J, Xu B, Zeng X, Shen K. Broncho-Vaxom in pediatric recurrent respiratory tract infections: A systematic review and meta-analysis. Int Immunopharmacol. 2018;54:198\u2013209.","journal-title":"Int Immunopharmacol"},{"key":"569_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00408-015-9737-3","volume":"193","author":"H Tang","year":"2015","unstructured":"Tang H, Fang Z, Sabor\u00edo GP, Xiu Q. Efficacy and safety of OM-85 in patients with chronic bronchitis and\/or chronic obstructive pulmonary disease. Lung. 2015;193:513\u20139.","journal-title":"Lung"},{"key":"569_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fmed.2014.00041","volume":"1","author":"C Pasquali","year":"2014","unstructured":"Pasquali C, Salami O, Taneja M, Gollwitzer ES, Trompette A, Pattaroni C, et al. Enhanced mucosal antibody production and protection against respiratory infections following an orally administered bacterial extract. Front Med. 2014;1:41.","journal-title":"Front Med"},{"key":"569_CR21","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/ACI.0000000000000433","volume":"18","author":"S Esposito","year":"2018","unstructured":"Esposito S, Soto-Martinez ME, Feleszko W, Jones MH, Shen KL, Schaad UB. Nonspecific immunomodulators for recurrent respiratory tract infections, wheezing and asthma in children: a systematic review of mechanistic and clinical evidence. Curr Opin Allergy Clin Immunol. 2018;18:198\u2013209.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"569_CR22","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1089\/jir.2013.0077","volume":"34","author":"Q Zhang","year":"2014","unstructured":"Zhang Q, Wang L, Wang C, Xu X, et al. OM85-BV induced the productions of IL-1\u03b2, IL-6, and TNF-\u03b1 via TLR4- and TLR2-mediated ERK1\/2\/NF-\u03baB pathway in RAW264.7 cells. J Interf Cytokine Res. 2014;34:526\u201336.","journal-title":"J Interf Cytokine Res"},{"key":"569_CR23","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/BF02718199","volume":"168","author":"J Wybran","year":"1990","unstructured":"Wybran J, Libin M, Schandene L. Activation of natural killer cells and cytokine production in humans by bacterial extracts (OM-85 BV). Lung. 1990;168:720\u20135.","journal-title":"Lung"},{"key":"569_CR24","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1136\/thorax.55.8.678","volume":"55","author":"M Roth","year":"2000","unstructured":"Roth M, Block LH. Distinct effects of Broncho-Vaxom (OM-85 BV) on gp130 binding cytokines. Thorax. 2000;55:678\u201384.","journal-title":"Thorax"},{"key":"569_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1136\/thx.51.2.150","volume":"1","author":"R Keul","year":"1996","unstructured":"Keul R, Roth M, Papakonstantinou E, Nauck M, Perruchoud AP, Block LH. Induction of interleukin 6 and interleukin 8 expression by Broncho-Vaxom (OM-85 BV) via C-Fos\/serum responsive element. Thorax. 1996;1:150\u20134.","journal-title":"Thorax"},{"key":"569_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep43844","volume":"7","author":"AT Dang","year":"2017","unstructured":"Dang AT, Pasquali C, Ludigs K, Guarda G. OM-85 is an immunomodulator of interferon-\u03b2 production and inflammasome activity. Sci Rep. 2017;7:43844.","journal-title":"Sci Rep"},{"key":"569_CR27","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF02718197","volume":"168","author":"WG Bessler","year":"1990","unstructured":"Bessler WG, Kleine B, Martinez Alonso C, Biesert L, Strecker M, Wiesm\u00fcller KH, et al. Biological activity of bacterial surface components: bacterial extracts and defined bacterial cell wall components as immunomodulators. Lung. 1990;168:707\u201315.","journal-title":"Lung"},{"key":"569_CR28","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0192-0561(97)00055-6","volume":"19","author":"WG Bessler","year":"1997","unstructured":"Bessler WG, Huber M, Baier W. Bacterial cell wall components as immunomodulators. II. The bacterial cell wall extract OM-85 BV as unspecific activator, immunogen and adjuvant in mice. Int J Immunopharmacol. 1997;19:551\u20138.","journal-title":"Int J Immunopharmacol"},{"key":"569_CR29","first-page":"209","volume":"10","author":"M Huber","year":"2005","unstructured":"Huber M, Mossmann H, Bessler WG. Th1-orientated immunological properties of the bacterial extract OM-85-BV. Eur J Med Res. 2005;10:209\u201317.","journal-title":"Eur J Med Res"},{"key":"569_CR30","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.intimp.2010.06.009","volume":"10","author":"WG Bessler","year":"2010","unstructured":"Bessler WG, Vor dem Esche U, Masihi N. The bacterial extract OM-85 BV protects mice against influenza and Salmonella infection. Int Immunopharmacol. 2010;10:1086\u201390.","journal-title":"Int Immunopharmacol"},{"key":"569_CR31","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1128\/IAI.69.6.3719-3727.2001","volume":"69","author":"LM Bowman","year":"2001","unstructured":"Bowman LM, Holt PG. Selective enhancement of systemic Th1 immunity in immunologically immature rats with an orally administered bacterial extract. Infect Immun. 2001;69:3719\u201327.","journal-title":"Infect Immun"},{"key":"569_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/mi.2010.51","volume":"4","author":"S Navarro","year":"2011","unstructured":"Navarro S, Cossalter G, Chiavaroli C, Kanda A, Fleury S, Lazzari A, et al. The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory T cells to the airways. Mucosal Immunol. 2011;4:53\u201365.","journal-title":"Mucosal Immunol"},{"key":"569_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082867","volume":"8","author":"C Parola","year":"2013","unstructured":"Parola C, Salogni L, Vaira X, Scutera S, Somma P, Salvi V, et al. Selective activation of human dendritic cells by OM-85 through a NF-kB and MAPK dependent pathway. PLoS One. 2013;8:e82867.","journal-title":"PLoS One"},{"key":"569_CR34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1165\/rcmb.2008-0260OC","volume":"42","author":"SE Evans","year":"2010","unstructured":"Evans SE, Scott BL, Clement CG, Larson DT, Kontoyiannis D, Lewis RE, et al. Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi. AmJ Respir Cell Mol Biol. 2010;42:40\u201350.","journal-title":"AmJ Respir Cell Mol Biol"},{"key":"569_CR35","first-page":"494","volume":"8","author":"V Manalova","year":"2017","unstructured":"Manalova V, Face A, Jeandet P, Bessler WC, Pasquali C. Biomarkers induced by the immunomodulator bacterial extract OM-85: unique roles for Peyer\u2019s patches and intestinal epithelial cells. J Clin Cell Immunol. 2017;8:494.","journal-title":"J Clin Cell Immunol"},{"key":"569_CR36","doi-asserted-by":"publisher","first-page":"e0188010","DOI":"10.1371\/journal.pone.0188010","volume":"12","author":"M Roth","year":"2017","unstructured":"Roth M, Pasquali C, Stolz D, Tamm M. Broncho Vaxom (OM-85) modulates rhinovirus docking proteins on human airway epithelial cells via Erk1\/2 mitogen activated protein kinase and cAMP. PLoS One. 2017;12:e0188010.","journal-title":"PLoS One"},{"key":"569_CR37","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1586\/ers.12.32","volume":"6","author":"DP Moore","year":"2012","unstructured":"Moore DP, Dagan R, Madhi SA. Respiratory viral and pneumococcal co-infection in the respiratory tract: implications of pneumococcal vaccination. Expert Rev Respir Med. 2012;6:451\u201365.","journal-title":"Expert Rev Respir Med"},{"key":"569_CR38","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jphs.2018.01.011","volume":"137","author":"H Li","year":"2018","unstructured":"Li H, Chen X, Zhou SJ. Dauricine combined with clindamycin inhibits severe pneumonia co-infected by influenza virus H5N1 and Strepotococcus pneumoniae in vitro and in vivo through NF-kB signaling pathway. J Pharm Sci. 2018;137:12\u20139.","journal-title":"J Pharm Sci"},{"key":"569_CR39","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.ijporl.2008.08.014","volume":"72","author":"A Salami","year":"2008","unstructured":"Salami A, Dellepiane M, Crippa B, Mora F, Guastini L, Jankowska B, et al. Sulphurous water inhalations in the prophylaxis of recurrent upper respiratory tract infections. Int J Pediatr Otorhinolaryngol. 2008;72:1717\u201322.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"569_CR40","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1128\/CMR.00058-05","volume":"19","author":"JA McCullers","year":"2006","unstructured":"McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev. 2006;19:571\u201382.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"569_CR41","doi-asserted-by":"publisher","first-page":"GRHTA.5000200","DOI":"10.5301\/GRHTA.5000200","volume":"2","author":"Roberto Ravasio","year":"2015","unstructured":"Ravasio R. Economic analysis of the immunostimulant OM-85 for the prevention of paediatric recurrent upper respiratory tract infections. Glob Reg Health Technol Assess. 2015; DOI: \n                    https:\/\/doi.org\/10.5301\/GRHTA.5000200\n                    \n                  .","journal-title":"Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish"},{"key":"569_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1055\/s-0037-1617412","volume":"39","author":"PAB Wark","year":"2018","unstructured":"Wark PAB, Ramsahai JM, Pathinayake P, Malik B, Bartlett NW. Respiratory viruses and asthma. Semin Respir Crit Care Med. 2018;39:45\u201355.","journal-title":"Semin Respir Crit Care Med"},{"key":"569_CR43","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1183\/09031936.00062714","volume":"45","author":"GA Rossi","year":"2015","unstructured":"Rossi GA, Colin AA. Infantile respiratory syncytial virus and human rhinovirus infections: respective role in inception and persistence of wheezing. Eur Respir J. 2015;45:774\u201389.","journal-title":"Eur Respir J"},{"key":"569_CR44","doi-asserted-by":"publisher","first-page":"S157","DOI":"10.1513\/AnnalsATS.201507-427AW","volume":"12","author":"JA Wedzicha","year":"2015","unstructured":"Wedzicha JA. Mechanisms of Chronic Obstructive Pulmonary Disease Exacerbations. Ann Am Thorac Soc. 2015;12:S157\u20139.","journal-title":"Ann Am Thorac Soc"},{"key":"569_CR45","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/S0140-6736(13)61536-6","volume":"382","author":"FD Martinez","year":"2013","unstructured":"Martinez FD, Vercelli D. Asthma. Lancet. 2013;382:1360\u201372.","journal-title":"Lancet"},{"key":"569_CR46","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10096-006-0166-3","volume":"25","author":"P Lehtinen","year":"2006","unstructured":"Lehtinen P, Jartti T, Virkki R, Vuorinen T, Leinonen M, Peltola V, et al. Bacterial coinfections in children with viral wheezing. Eur J Clin Microbiol Infect Dis. 2006;25:463\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"569_CR47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/ACI.0000000000000344","volume":"17","author":"A Beigelman","year":"2017","unstructured":"Beigelman A, Bacharier LB. Management of preschool recurrent wheezing and asthma: a phenotype-based approach. Curr Opin Allergy Clin Immunol. 2017;17:131\u20138.","journal-title":"Curr Opin Allergy Clin Immunol"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-018-0569-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13052-018-0569-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-018-0569-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T19:12:04Z","timestamp":1569438724000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-018-0569-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,26]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["569"],"URL":"https:\/\/doi.org\/10.1186\/s13052-018-0569-7","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,26]]},"assertion":[{"value":"5 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal experiments were performed in accordance with the Institutional Guidelines and Swiss Federal and Cantonal Laws on Animal Protection.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"G.A. Rossi is an active consultant for OM Pharma SA, a company of the Vifor Pharma Group, Geneva, Switzerland; W. Bessler is honorarium professor and invited guest at Albert-Ludwigs-Universit\u00e4t Freiburg, Germany; S. Ballarini is an employee of OM Pharma SA, a company of the Vifor Pharma Group, Geneva, Switzerland; C. Pasquali is an employee of OM Pharma SA, a company of the Vifor Pharma Group, Geneva,, Switzerland.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"112"}}